SGI-DNA Launches BioXp™ 3200 System Beta-Testing of a Cloning Module to Provide Scientists the Unprecedented Ability to Synthesize and Clone DNA Virtually Hands-Free

La Jolla, CA — December 3, 2015 — SGI-DNA Inc., a Synthetic Genomics Inc. company, announces the launch of beta-testing of the BioXp™ 3200 System Cloning Module, equipping researchers with the ability to synthesize and clone their DNA with an overnight instrument run. The benchtop BioXp™ System, the world’s first DNA printer, is a genomic workstation that generates high-quality DNA from custom designed reagents. Now, with the introduction of the Cloning Module, the BioXp™ System has the additional capability to assemble and simultaneously deliver up to 24 DNA clones from custom DNA sequences submitted electronically. The launch of this first-of-its-kind module allows researchers the ability to obtain cloned de novo DNA fragments in the laboratory virtually hands-free, further automating and shortening molecular biology work flows without relying on a service company.

Development and release of the BioXp™ System Cloning Module marks the first additional application since our early access release in April of 2015. Integrating Gibson Assembly® technology within the automated BioXp™ System workflow empowers customers with the ability to focus on scientific discovery and analytics by releasing users from traditional hands-on, time‑intensive, tedious DNA cloning methods.

“It’s truly exciting that the technologies we developed for simplifying molecular biology are now being automated by the BioXp™ System,” said Daniel Gibson, Ph.D., Vice President of DNA Technology at SGI. “The cloning module is very important as it will pave the way to help researchers streamline the study of genes and gene families at an unprecedented rate.”

BioXp™ System customers are at the forefront of genomics innovation as it is poised to meet the growing demand for large-scale, automated DNA synthesis and cloning projects of both the academic and commercial life science community.

For more information on the Assembly and Cloning Module of the BioXp™ 3200 System, visit

All products are for research use only and are not intended for diagnostic uses.

The Gibson Assembly® method is also available under commercial license. For more information, contact us at

About the Gibson Assembly® Method

The Gibson Assembly® method was developed in 2009 by Dan Gibson, Ph.D., and his colleagues at the J. Craig Venter Institute during the team’s quest to construct the first synthetic cell.  Since its introduction, the Gibson Assembly® method has become a mainstay in many synthetic biology laboratories and has attracted interest from both the academic and commercial life sciences community due to its ease-of-use, robustness, and flexibility.


SGI-DNA, a wholly owned subsidiary of Synthetic Genomics, Inc. (SGI), is responsible for all commercial aspects of SGI’s synthetic DNA business and focuses on strategic business relationships with both academic and commercial entities. Building on the scientific advancements and breakthroughs from leading scientists such as J. Craig Venter, Hamilton Smith, Clyde Hutchison, Dan Gibson and their teams, SGI-DNA utilizes unique and proprietary DNA technologies to produce complex synthetic genes and reagents. SGI-DNA also offers a comprehensive suite of genomic services, including whole genome sequencing, library design, bioinformatics, cell engineering, and plasmid DNA services.

Media Contact

Mary Canady, 858-433-4994,